---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-24-000582"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T10:35:47.422176+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q1 2024: revenue up 5.7% to $312.3M; adjusted EPS $0.79 beats; guidance trimmed on FX headwinds

## Summary
- GAAP diluted EPS $0.63 vs $0.06 in Q1 2023; adjusted EPS $0.79, up 19.7% YoY.
- Revenue $312.3M (+5.7% as reported, +5.9% constant currency); domestic +7.2%, international +3.8%.
- General Surgery revenue grew 8.0% as reported; Orthopedic Surgery +2.8%.
- FY2024 revenue guidance lowered to $1.330-1.355B (prev $1.340-1.365B) due to ~$10M FX headwind.
- Adjusted EBITDA $56.3M, margin 18.0% vs 17.3% in Q1 2023.

## SEC filing metadata
- accession: 0001174947-24-000582
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494724000582/0001174947-24-000582-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494724000582/form8k-32144_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-24-000582
- JSON: https://secwatch.observer/filing/0001174947-24-000582.json
- Plain text: https://secwatch.observer/filing/0001174947-24-000582.txt

## Key facts
- Earnings Releases
  CONMED Corp reported first quarter ended March 31, 2024 results: revenue $312.3 million.
  - Period: first quarter ended March 31, 2024
  - Revenue: $312.3 million
  - Result: reported results
  source text: Florida, April 24, 2024 – CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights · Sales of $312.3 million increased 5.7% year-over-year as reported and 5.9% in constant currency. · Domestic revenue increased 7.2% year-over-year. · International revenue increased 3.8% year-over-year
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494724000582/0001174947-24-000582-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.